Silvant Capital Management LLC Invests $1.68 Million in Cigna Group $CI

Key Points

• Silvant Capital Management purchased 6,105 shares of Cigna, valued at approximately $1.68 million, while institutional investors collectively own 86.99% of the company.
• Cigna reported quarterly earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company reaffirmed fiscal 2026 earnings guidance of approximately $30.45 per share.
• Cigna announced a quarterly dividend of $1.56 per share, equivalent to an annualized $6.24 payout and a 2.3% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $339.45.

Silvant Capital Management LLC purchased a new stake in Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 6,105 shares of the health services provider's stock, valued at approximately $1,683,000.

Other institutional investors have also added to or reduced their stakes in the company. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group during the fourth quarter worth about $25,000. Cedar Mountain Advisors LLC increased its holdings in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after buying an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group during the 2nd quarter valued at $29,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the 4th quarter worth $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group during the 4th quarter worth $29,000. 86.99% of the stock is currently owned by institutional investors.

Insider Transactions at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,677 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company's stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

CI stock opened at $274.50 on Friday. The firm has a market cap of $72.53 billion, a P/E ratio of 11.36, a P/E/G ratio of 0.95 and a beta of 0.29. The firm's fifty day moving average is $284.63 and its 200 day moving average is $281.41. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm posted $7.20 earnings per share. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's payout ratio is 25.82%.

Analysts Set New Price Targets

CI has been the topic of a number of research analyst reports. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, May 22nd. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and dropped their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Raymond James Financial cut Cigna Group from a "strong-buy" rating to an "outperform" rating and cut their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Cantor Fitzgerald increased their price objective on Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research report on Friday, May 1st. Finally, Sanford C. Bernstein raised their price objective on Cigna Group from $371.00 to $381.00 and gave the company an "outperform" rating in a report on Thursday, July 9th. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and an average price target of $339.45.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source